Inactivated vaccines derived from bovine viral diarrhea virus B3 strain elicit robust and specific humoral and cellular immune responses
Frontiers in Microbiology · 08.08.2025 · 16
DOI: 10.3389/fmicb.2025.1607334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 08.08.2025. Verfasst von Ming-Guo Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Shihezi University, Shihezi, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Bovine viral diarrhea-mucosal disease (BVD-MD) is a significant viral disease in cattle caused by infection with bovine viral diarrhea virus (BVDV). Xinjiang, a major pastoral region in China, is heavily affected by this disease. Owing to the high genetic variability of BVDV, developing cross-protection vaccines targeting predominant strains is essential.
Methods
In this study, inactivated vaccines were developed using BVDV strains isolated from Xinjiang, including BVDV-1 (B1), BVDV-2 (B2), XJ-BVDV-3 (B3), and BVDV-LC (LC). BALB/c mice were immunized, and immune responses were assessed via ELISpot, ELISA, and virus neutralization assays. On day 42 post-immunization, the mice were challenged with BVDV, and the viral loads were quantified.
Results
The vaccines showed stable characteristics and sterility and are suitable for immunization studies. All the vaccines stimulated interferon-gamma (IFN-γ) production, and the IFN-γ levels in the B1 and B3 groups were significantly higher than those in the commercial vaccine group ( p < 0.0001). The ELISA results revealed specific IgG, IgG1, and IgG2a antibodies. Neutralization assays revealed that the B3- and LC-inactivated vaccine groups presented significantly higher neutralizing antibody titers than did the commercial vaccine group (( p < 0.05). Tissue viral load detection revealed that the inactivated vaccines reduced the viral load across various tissues.
Discussion
In conclusion, this study developed inactivated vaccines from the B1, B2, B3, and LC strains, all of which induce robust immune responses. Among these, the B3 inactivated vaccine show great potential for commercialization, providing a valuable reference for BVDV prevention and control in Xinjiang.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Animal Science and Technology, Shihezi University, Shihezi, China.
- Changji Hui Autonomous Prefecture Animal Disease Prevention and Control Center, Changji, China.
- Department of Biotechnology, Linxia Modern Career Academy, Linxia, China.
- College of Animal Science and Technology, Xinyang Agriculture and Forestry University, Xinyang, China.
Zitieren
APA
Xu, M. G., Wu, A. D., Liu, J. N., Yang, Z. L., Li, H. H., Ma, H. L., Yang, N. N., Sheng, J. L., & Chen, C. F. (2025). Inactivated vaccines derived from bovine viral diarrhea virus B3 strain elicit robust and specific humoral and cellular immune responses. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1607334
Vancouver
Xu MG, Wu AD, Liu JN, Yang ZL, Li HH, Ma HL, et al. Inactivated vaccines derived from bovine viral diarrhea virus B3 strain elicit robust and specific humoral and cellular immune responses. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1607334
BibTeX
@article{Xu2025,
author = {Xu, Ming-Guo and Wu, Ao-Di and Liu, Jing-Nan and Yang, Zhong-Lian and Li, Hong-Huan and Ma, Hai-Long and Yang, Ning-Ning and Sheng, Jin-Liang and Chen, Chuang-Fu},
title = {Inactivated vaccines derived from bovine viral diarrhea virus B3 strain elicit robust and specific humoral and cellular immune responses},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1607334}
}
EUVIMED